Showing results (61-70 of 261) with videos related to

Sort By:
Pageof 27
The New England Journal of Medicine|June 12, 2024
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell TherapyMetin Ozdemirli, Thomas M Loughney, Emre Deniz, et al.
Haematologica|June 30, 2016
Donor and recipient sex in allogeneic stem cell transplantation: what really mattersHaesook T Kim, Mei-Jie Zhang, Ann E Woolfrey, et al.
Blood|March 31, 2017
PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphomaLakshmi Nayak, Fabio M Iwamoto, Ann LaCasce, et al.
Transplantation and Cellular Therapy|August 27, 2021
Outcomes and Utilization Trends of Front-Line Autologous Hematopoietic Cell Transplantation for Mantle Cell LymphomaPeter A Riedell, Mehdi Hamadani, Kwang W Ahn, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 6, 2017
High-dose Thiotepa, Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation as Upfront Consolidation for Systemic Non-Hodgkin Lymphoma With Synchronous Central Nervous System InvolvementDavid Qualls, Andrew Sullivan, Shuli Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantationVincent T Ho, Julie Aldridge, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 1, 2013
Outcome and prognostic factors for patients who relapse after allogeneic hematopoietic stem cell transplantationGita Thanarajasingam, Haesook T Kim, Corey Cutler, et al.
Blood Advances|July 16, 2025
Estimating efficacy of favezelimab plus pembrolizumab relative to pembrolizumab in anti-PD-1-refractory Hodgkin lymphomaPhilippe Armand, Pier Luigi Zinzani, John M Timmerman, et al.
Leukemia & Lymphoma|July 22, 2024
A phase I trial of vaccination with lethally irradiated lymphoma cells admixed with granulocyte-macrophage colony-stimulating factor secreting K562 cells for the treatment of follicular lymphomaEric Jacobsen, Ashley Plant, Robert Redd, et al.
Haematologica|July 2, 2026
Anti-CD47 antibody magrolimab with pembrolizumab in patients with relapsed / refractory classic Hodgkin lymphomaJoseph G Schroers-Martin, Reid Merryman, Michael A Spinner, et al.
Pageof 27